Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
The point is why psoriasis and not lupus or sepsis all are equally important and possible indications to go for ... there must have been some sort of evidence gathered ... Whatever the case we will find out soon ... ATB Mafuta
It's worth pondering why psoriasis was the chosen route for 1801 .this was no stab in the dark or Mmmmm what shall we go for .... There must have been some early indication that this was the best condition to aim at because of some evidence ... It will all come out of the wash eventually ... I think next week may be interesting ... LH&K Mafuta
Yes your posting history gives me alarm bells
Was indeed a bitter pill to swallow ... I really thought the return of 737 had been factored in by the 2 day consecutive drop just before the news landed ... The consequent drop was way way over done and I think somewhat manufactured ... Great research SOG et al ... your line of reasoning makes a lot of sense thanks ... we should find out in the not too distant future ... I'm happy to wait a bit as I have other funds to live off ... sorry for all those who lost out though ... LH&K Mafuta
Surfie/Elcap ... The reason I feel sorry is that many sold at a loss or got their stop losses taken out, no one likes that to happen ... it's not sensisble to take things out of context and assume you know the sentiment behind words ... you don't know me and I don't know you either ... it would have been helpful if you had asked what I meant by my comments rather than trying to judge me ... whatever the case I hope everyone has a better day than yesterday. As for one I suffered a £15k paper loss yesterday ... LH&K Mafuta
And our Dr. Parker tweeted this yesterday:
"A little know compound, SDC 1801 is going P1a this year and is direct competitor for BMS, able to differentiate with dual inhibition. "
Notice "... SDC 1801 is going P1a this year..." Not maybe bit IS.
Have a good day everyone.
I think SOG has assessed the situation well ... And we now have an ideal opportunity to get a bigger slice ( if not all) of 737 ... I was not spooked by yesterday's nonsense ... After all we've seen it all before ... The only thing is I feel somewhat sorry for those who panicked and bailed out early ... I'm also sad I didn't have the funds to scoop some more up yesterday ... The only winners were the MMs and their clients ... As RMM reminds us we are no one trick pony ... and when this horse runs it runs very fast as yesterday's movement proved ... LH&K Mafuta
We see this latest development as a mild setback for Sareum given that GSK’s support could have accelerated development activity on the drug, triggering a $0.55m payment to Sareum from first patient dosing in a new clinical trial. However, it does provide Sareum and partner CPF with an opportunity to actively assess future development plans for SRA737, leveraging the positive clinical data.
Calling someone you don't know dishonest really sums you up ... I don't wish you or anyone else any harm, I was just expressing an opinion ... Which I guess is the raison d'etre for chat rooms? ... Sorry to say I won't be missing your inessant moaning ... I hope you do well elsewhere ... and have a restful night ... you'll feel better in the morning once you've sold out ...LH&K Mafuta
Utah I was being polite ... However when you do sell up and go hopefully we won't have to listen to your negative drivel ... Best to sell at market open ... Put your sell in and when you wake up tomorrow you'll be a liberated person ... LH&K Mafuta